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Dear Editor 
The editorial by Dr Malo on compensating occu- 
pational asthma (Respir Med 87, 569-570) was a 
useful summary of the principles and points to be 
considered. However, his conclusions are in some 
respects unrealistic, at least in the U.K. setting. He 
suggests that a diagnosis of occupational asthma 
should be confirmed by objective means before 
claims for compensation are accepted. In practice, 
many claimants have long ago left the relevant 
employment by the time they are assessed by a 
respiratory physician so that peak flow monitoring at 
work is impossible. Facilities for specific bronchial 
challenge are few in the UK and some doctors 
operating them feel that it is inappropriate to use a 
procedure which is not entirely without risk purely 
for the purposes of establishing the right to compen- 
sation, preferring to reserve it for cases in which an 
important decision must be made as to whether an 
individual should be allowed to remain in a particular 
employment. For those still in the relevant employ- 
ment, Dr Malo suggests that workplace challenges 
with FEV, recording are preferable to peak flow 
monitoring. This may be so, but in practice they are 
very difficult to organize without the full cooperation 
of the employer which is frequently not forthcoming. 
Indeed, it is by no means uncommon for a worker 
seen to be measuring his own peak flow to be 
transferred to another job to prevent him obtaining 
evidence that he has occupational asthma and 
thereby make his claim at common law against the 
employer more difficult to establish. Perhaps employ- 
ers are obliged to be more cooperative in Montreal. 
Although I would not disagree with Dr Malo’s 
recommendations as a counsel of perfection, in prac- 
tice it is often necessary to accept a diagnosis of 
occupational asthma on a balance of probabilities 
basis. The worker should not be denied compen- 
sation simply because it is impractical to obtain 
objective evidence to substantiate his claim. 
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